Neonates frequently suffer from neurological disorders and epileptic seizures causing serious brain injuries, lifelong disabilities or even childhood death. Today, brain monitoring of neonates in intensive care units is based on manual EEG data interpretation. Recent medical studies and feedback from clinicians recommend the addition of NIRS as a complementary modality to improve monitoring quality for (contra-) indication in a combined EEG/NIRS monitoring device, and to automate monitoring.
Our target customers are hospitals with neonatal intensive care units. A phased market-entry strategy into key worldwide markets is planned, generating revenue through sold systems, consumables, and services. Eemagine Medical Imaging Solutions has a strong footing in these target markets and can build on a valuable client-base and distributor network. They will assemble and market the final product. Profit will be shared between the SMEs. Austrian institute of Technology’s contribution will be compensated by a license fee per sold unit.